Hematocrit on a Blood Test: What the Percentage Means

Hematocrit is the proportion of your blood volume made up of red cells, reported as a percentage. A hematocrit of 45% means red cells occupy 45% of the volume and plasma and white cells account for the rest.

It is one of the oldest measurements in hematology, and on a modern analyser it is usually not measured at all.

How is hematocrit actually determined?

Historically by spinning a capillary tube and reading the packed red cell column directly. Most automated analysers now calculate it instead, from the red cell count and MCV — cell number multiplied by average cell size gives the volume those cells occupy.

That matters for interpretation. A calculated hematocrit inherits any error in the count or in MCV, which is part of why it moves in step with those indices and why MCHC — which divides hemoglobin by hematocrit — is the index most vulnerable to artefact.

Hydration also moves it. Because it is a ratio of cells to total volume, dehydration concentrates the blood and raises hematocrit without a single extra red cell being produced.

What counts as a high hematocrit?

The WHO thresholds for polycythemia are 49% in men and 48% in women. Values above those are the point at which a genuine excess of red cell mass is considered rather than assumed away.

	Threshold
Polycythemia (WHO)	≥49% men · ≥48% women
Studied risk threshold	≥45% in the TAMRISK cohort
Common transient cause	Dehydration — raises the ratio, not the cell mass

Below the polycythemia thresholds, a raised hematocrit is far more often about plasma volume, altitude, smoking, sleep apnea, or testosterone therapy than about a marrow disorder.

Does high hematocrit predict cardiovascular disease?

This is where the honest answer is narrower than the usual summary, and the detail is worth having.

The Tampere Adult Population Cardiovascular Risk study followed 886 subjects for 30 years, measuring hematocrit at age 35 and outcomes to age 65. Comparing HCT ≥45% against <45% at baseline:

Hypertension by age 60 — associated, and it held under full adjustment: OR 1.7 (95% CI 1.2–2.5), p = 0.007.
Coronary artery disease by age 60 — associated when adjusted for BMI alone (OR 1.7, 95% CI 1.0–2.7), but the association was abolished with full adjustment (p = 0.912).
Cardiovascular mortality by age 65 — striking on BMI adjustment alone (OR 3.9, 95% CI 1.2–13.0), and again eliminated with full adjustment (p = 0.477).

The headline number here would be a nearly fourfold cardiovascular mortality risk. It did not survive adjustment for the other things that travel with a high hematocrit. The finding that did survive was hypertension.

That pattern — a large crude association shrinking to nothing once confounders are accounted for — is the ordinary shape of biomarker epidemiology, and it is the part most write-ups omit.

The same paper cites an older finding that men with HCT ≥50% were 2.4 times more likely to die from coronary heart disease over 28 years. That is a historical comparison in a different cohort, and it should be read alongside the adjusted results above rather than instead of them.

Where high hematocrit genuinely does drive risk

In polycythemia vera, a myeloproliferative disorder, the relationship is causal rather than associative: raised red cell mass increases blood viscosity and thrombotic risk, and hematocrit control is a treatment target rather than a marker to observe.

That is a defined disease, diagnosed on more than a percentage, and it is a different situation from a mildly raised hematocrit on a routine panel.

Frequently asked questions

What is a normal hematocrit?

Reference ranges differ by sex and laboratory, typically running around 40–52% in men and 36–48% in women. The WHO polycythemia thresholds sit at 49% and 48% respectively.

Can dehydration cause a high hematocrit?

Yes, and it is one of the most common explanations. Hematocrit is a ratio of red cells to total blood volume, so losing plasma volume raises the percentage without changing red cell mass. A repeat test when properly hydrated often resolves a borderline result.

Does testosterone therapy raise hematocrit?

It is a recognised effect, and it is why hematocrit is monitored during therapy. This is one of the situations where a rising percentage reflects a real increase in red cell production rather than a volume artefact.

Is a hematocrit of 46% dangerous?

It is below the WHO polycythemia thresholds and would not be flagged by most laboratories. In the TAMRISK cohort the ≥45% group had higher odds of developing hypertension over 30 years, but the cardiovascular mortality association did not survive full adjustment. It is a number worth tracking in context, not one to act on alone.

What is the difference between hematocrit and hemoglobin?

Hemoglobin is the concentration of oxygen-carrying protein; hematocrit is the volume fraction the cells carrying it occupy. They move together in most conditions, and hematocrit is roughly three times the hemoglobin value in g/dL as a rough clinical shorthand.

The takeaway

Hematocrit is a volume ratio, usually calculated rather than measured, and readily moved by hydration. That makes a single raised value a weak signal on its own.

The long-term data is more nuanced than it is usually presented. In a 30-year cohort, a hematocrit at or above 45% in early middle age predicted hypertension decades later — but the coronary disease and cardiovascular mortality associations both disappeared once other risk factors were accounted for. Where high hematocrit genuinely drives events is in polycythemia vera, which is a diagnosis rather than a reading.

For anyone tracking their own panel, the useful posture is the one that applies across these indices: watch the trend, interpret it next to the rest of the count, and take a persistent elevation to a clinician rather than to a search engine.